Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03435562 · ClinicalTrials.gov registry record · NA
Assessment of Two New Electronic Cigarettes in Cigarette Smokers
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03435562 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 22 participants.
The verdict
NCT03435562, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.
Interventions
- OTHER JUUL electronic cigarette
- OTHER IQOS electronic cigarette
- OTHER Own Brand cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-03-03 |
| Est. Completion | 2019-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03435562
The ClinicalTrials.gov registry entry for NCT03435562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which JUUL electronic cigarette is the first listed.
NCT03435562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03435562 about?
NCT03435562 is a clinical study titled "Assessment of Two New Electronic Cigarettes in Cigarette Smokers". The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.
What is the current status of trial NCT03435562?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-03-03. Estimated completion is 2019-08-16.
What interventions are being tested in trial NCT03435562?
The interventions under investigation include: JUUL electronic cigarette (OTHER), IQOS electronic cigarette (OTHER), Own Brand cigarette (OTHER).
Who is sponsoring clinical trial NCT03435562?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.